Pharmacogenomics. 2013;14(6):665-674. TPH1 121 MDD and BD patients treated with paroxetine Association between A/A and A/C variants of rs1800532 and poor response to paroxetine treatment when compared ...
Dr. Mirko Manchia at a recent national conference on neuropsychopharmacology in Rome discussing precision medicine approaches in psychiatry. CAGLIARI, Sardinia, Italy, 8 July 2025 – In a comprehensive ...
Pharmacogenomics (PGx) involves the study of patients’ unique genes to predict their individual response to drugs. 1,3 In assessments of the 12 most important pharmacogenes, at least 1 clinically ...
Pharmacogenomics is a tool that can assist providers in optimizing drug selection and dosing, help avoid costly adverse effects, and identify responders and non-responders to medications. New and ...
Please provide your email address to receive an email when new articles are posted on . Pharmacists can play a key role in integrating pharmacogenomics data into clinical practice. Antiplatelet, ...
In a report recently published in the American Journal of Health-System Pharmacy, the Ochsner Health system delves into the multifaceted implementation of pharmacogenomics—a rapidly evolving field ...
Incorporating aquatic therapy can enhance patient outcomes and shorten recovery times for health care professionals. In the Chicago suburbs, the demand for such programs is rising. With any prognosis, ...
As part of this initiative, PGxAI will roll out a suite of pharmacogenomic reports on Sequencing.com that provide personalized drug implications based on an individual’s genomic data. They directly ...
Pharmacogenomics helps reduce the occurrence of polypharmacy. The tailored drug treatment reduces the need for patients to take several medications to treat the same condition. As a result, there are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback